Amedisys (AMED) reported 571.41millioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof2.71.03 for the same period compares to 1.00ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof564.58 million, representing a surprise of +1.21%. The company delivered an EPS surprise of +1.98%, with the consensus EPS estimate being $1.01.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...